Concepedia

Marco Gross‐Langenhoff

MG

Statistics

Publications

4

Citations

196

H-Index

4

Active since

2005

Affiliations

Astellas Pharma (Germany)(Current)

University of Tübingen

Marco Gross‐Langenhoff is an author at Astellas Pharma (Germany) specializing in signal transduction, natural sciences, and cellular biochemistry.

Top concepts

Publications per year

2005–2022

4

Publications

4

cAMP Is a Ligand for the Tandem GAF Domain of Human Phosphodiesterase 10 and cGMP for the Tandem GAF Domain of Phosphodiesterase 11

Marco Gross‐Langenhoff, Karina Hofbauer, Jost Holger Weber et al. · Journal of Biological Chemistry · 2005 · 123 citations · Full text

Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib

Alexander E. Perl, Naoko Hosono, Pau Montesinos et al. · Blood Cancer Journal · 2022 · 43 citations · Full text

The properties of phosphodiesterase 11A4 GAF domains are regulated by modifications in its N‐terminal domain

Marco Gross‐Langenhoff, Arnulf Stenzl, Florian Altenberend et al. · FEBS Journal · 2008 · 15 citations · Full text

, , +17

Efficacy and Tolerability of Leuprorelin Acetate (Eligard®) in Daily Practice in Germany: Pooled Data from 2 Prospective, Non-Interventional Studies with 3- or 6-Month Depot Formulations in Patients with Advanced Prostate Cancer

Carsten‐Henning Ohlmann, Marco Gross‐Langenhoff · Urologia Internationalis · 2017 · 15 citations

1–4 of 4